Tessa Reardon summarises a systematic review, which reports on the specific clinical and psychological factors that predict persistent anxiety disorders.
[read the full story...]Persistent anxiety disorders: who is most at risk?
No Responses »
Mental health during the Covid-19 pandemic: the impact on low and middle income countries
A recent review which looks at the mental health impact of the COVID pandemic on different low- and middle-income countries.
[read the full story...]Choosing between antipsychotics to reduce the risk of breast cancer in women with schizophrenia
Peter Knapp and Suzy Ker review a recent study from Finland, which suggests that women with schizophrenia who take prolactin-increasing antipsychotics for at least five years, have an increased risk of developing breast cancer.
[read the full story...]Mapping the links between leisure activities and health outcomes: the Multilevel Leisure Mechanism Framework
Alice Potter summarises a narrative review and multi-level theoretical framework of mechanisms of action on how leisure activities affect health.
[read the full story...]The benefits and harms of antidepressants for youth depression and anxiety #ActiveIngredientsMH
Mark Horowitz and Joanna Moncrieff consider a new #ActiveIngredientsMH review published today in The Lancet Psychiatry, which looks at the knowns and unknowns of antidepressant treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action.
[read the full story...]Suicide rates in the early stages of the COVID-19 pandemic: cross-national data provide no evidence of an increase
Karel Kieslich, Rosalind McAlpine and Alexandra Pitman review a recent study exploring suicide trends in the early months of the COVID-19 pandemic with real-time data from 21 countries.
[read the full story...]Long-acting injectable antipsychotics: more effective than oral medications at preventing hospitalisation and relapse in schizophrenia according to new review
Joseph Pierre appraises a recent meta-analysis on long-acting injectable antipsychotics compared to oral antipsychotic medication for the maintenance treatment of schizophrenia.
[read the full story...]Could a decision support tool help to guide mental health treatment in primary care?
Linda Gask reviews a recent randomised controlled trial on the clinical efficacy of a Decision Support Tool (Link-me) to “guide the intensity of mental health care in primary practice”.
[read the full story...]Will the COVID-19 pandemic lead to a mental health pandemic?
In his debut blog, KCL student George Bougas explores a recent longitudinal study looking at mental health outcomes before and during the COVID-19 pandemic in the UK.
[read the full story...]Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for Black, Asian and Minority Ethnic mental health #AntiRacistMHResearch
Today, following the #AntiRacistMHResearch webinar (11/5/21) on Achieving Equity in Mental Health Research with Dr Lade Smith, we publish the full version of a letter written by Dr Smith and colleagues to The Lancet Psychiatry last year.
[read the full story...]